MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

This study has been completed.

Study NCT00020579 Information provided by National Cancer Institute (NCI)

First Received: July 11, 2001 Last Updated: April 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	April 2008 (Final data collection date for primary outcome measure)

Publications:

Ryan QC, Headlee D, Sparreboom A, et al.: A phase I trial of an oral histone deacetylase inhibitor, MS-275, in advanced solid tumor and lymphoma patients. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-802, 2003.